Bora News

  1. Meet Bora at Bio Asia–Taiwan 2025 | Booth M720 7/4/2025

    Bora will be attending Bio Asia–Taiwan 2025 from July 23 to 27 at the Taipei Nangang Exhibition Center. Visit us at the CDMO zone, Booth M720, to discuss how end-to-end solutions in pharmaceutical and biologics development and manufacturing can help accelerate better health and the pipeline to commercial success.

  2. Bora Pharmaceuticals Wins World Finance Sustainability Award 2025 6/23/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, today announced that it has been named a winner of the World Finance Sustainability Awards 2025, in recognition of its industry-leading efforts to embed sustainability into the heart of its operations.

  3. Bora Adds Automated Fill/Finish Line In Baltimore 5/29/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, today announced that due to continued growth in demand for its drug product services, it plans to add further sterile fill/finish capacity at its facility in Baltimore, Maryland.

  4. Bora Appoints Industry Veteran As Chief Commercial Officer 5/13/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, today announced the appointment of Jean-Baptiste (“JB”) Agnus as Chief Commercial Officer.

  5. Bora Health Partners With National Taiwan University Hospital And Patient Groups To Raise Awareness On World Parkinson's Day 4/11/2025

    April 11 is World Parkinson’s Day. To mark the occasion, the Center for Parkinson and Movement Disorders at National Taiwan University Hospital (NTUH), the Taiwan Parkinson’s Disease Association, and Bora Health jointly organized a public event titled “Move Your Body and Mind: A Collaborative Treasure Hunt for World Parkinson’s Day.”

  6. Bora Wins Prestigious CDMO Leadership Awards 3/20/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”), a global leader in pharmaceutical manufacturing, today celebrated winning three Outsourced Pharma Leadership Awards: Best New or Transformed CDMO, Biologics – Global, and Small Molecule Dosage Form – Global.

  7. Tanvex BioPharma Completes Acquisition Of Bora Biologics, Launching New Era In Biologics Development 1/19/2025

    Tanvex BioPharma, Inc. ("Tanvex"), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars products company, is pleased to announce the successful completion of its acquisition of Bora Biologics Co., Ltd. ("Bora Biologics"), a subsidiary of Bora Pharmaceuticals. Following this acquisition, Tanvex's CDMO services will operate under the name Bora Biologics, continuing to be owned by Tanvex.

  8. Bora Company Presentation At 43rd Annual J.P. Morgan Healthcare Conference 1/16/2025

    Bora Pharmaceuticals has been invited to participate in the prestigious J.P. Morgan Healthcare Conference and will be hosting a company presentation on January 16, 2025, at 2:15pm PST.

  9. Bora Biologics Announces Strategic Collaboration To Accelerate Key CMC Development Of DotBio's Tri-Specific Antibody To Treat Cancer 1/8/2025

    Bora Biologics, a fast-growing division of leading contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, today announced that it will support DotBio, a Singaporean biopharmaceutical company specializing in next-generation antibody therapies, in the development and manufacturing of DotBio’s lead asset, a novel tri-specific antibody, code name DB007, against undisclosed cancer targets.

  10. Bora Pharmaceuticals Announces Unveiling Of New Multi-Purpose Small Molecule Site In Zhongli, Taiwan  1/7/2025

    Bora Pharmaceuticals Co., Ltd., a global cGMP contract development and manufacturing organization (CDMO), is pleased to announce the grand unveiling of its new small molecule dose form facility in Zhongli, Taiwan.